跳至主要内容
临床试验/NCT05078528
NCT05078528招募中不适用

Low-cost Mobile Colposcopy and Confocal Imaging for Global Prevention of Cervical Cancer

Barretos Cancer Hospital4 个研究点 分布在 1 个国家目标入组 1,060 人开始时间: 2021年9月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,060
试验地点
4
主要终点
Develop and validate a Multimodal Mobile Colposcope (MMC)

研究概览

简要总结

Cervical cancer remains the first or second leading cause of cancer death among women in many low-and middle-income countries. Cervical cancer prevention programs in low-resource settings are hampered by a lack of personnel with appropriate clinical expertise, lack of pathology services, and lack of associated infrastructure. There is an urgent need for appropriate diagnostic tools to enable accurate screening and diagnosis in low-resource settings. The purpose of this study is to develop and validate a low-cost Multimodal Mobile Colposcope (MMC) for global cervical cancer prevention programs. This new device will combine the imaging capabilities of a mobile colposcope with the microscopic imaging capabilities of a fiber-optic confocal imaging probe.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
25 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women >25 years of age;
  • Women undergoing colposcopy due to abnormal cervical screening or follow-up for a history of dysplasia;
  • Women of childbearing potential must have a negative urine or blood pregnancy test;
  • Ability to understand and willingness to provide informed consent by signing specific Informed Consent Document.

排除标准

  • Women under 25 years of age;
  • Women who have undergone hysterectomy with removal of the cervix;
  • Women with known allergy to proflavine or acriflavine;
  • Women who are pregnant or nursing at the time of enrollment;
  • Incapacitated women or in vulnerable situations or who are not willing to give consent;

结局指标

主要结局

Develop and validate a Multimodal Mobile Colposcope (MMC)

时间窗: Day 1 - at the colposcopy day

Image data will be used as a training set to develop and refine image analysis algorithms. Multimodal Mobile Colposcope will be compared with colposcopic impression considering clinical performance (sensitivity, specificity, positive and negative predictive values, and area under the Receiver Operating Characteristic (ROC) curve)

次要结局

未报告次要终点

研究者

发起方
Barretos Cancer Hospital
申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

进行中(未招募)
不适用
Clinical Trial of Minimally Invasive Surgery Versus Abdominal Surgery in Patients With Early Stage Cervical CancerUterine Cervical Neoplasm
NCT03955185Huazhong University of Science and Technology2,000
终止
2 期
First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical CancerStage IVB Cervical CancerRecurrent Cervical CancerPersistent Cervical Cancer
NCT04974944Sun Yat-Sen University Cancer Center35
Unknown
不适用
Screening and Identification of Biomarkers on Cervical CancersCervical Cancer
NCT00854269National Taiwan University Hospital250
进行中(未招募)
不适用
Primary Cervical Cancer Screening by Self-sampling HPV TestNegative For Intraepithelial Lesion Or MalignancyAtypical Squamous Cells of Undetermined SignificanceAtypical Squamous Cells, Cannot Rule Out High-grade Squamous Intraepithelial LesionLow-Grade Squamous Intraepithelial LesionsCervical CancerHigh-Grade Squamous Intraepithelial LesionsCervical Intraepithelial Neoplasia Grade ICervical Intraepithelial Neoplasia Grade IICervical Intraepithelial Neoplasia, Grade IIIAtypical Glandular CellsAtypical Glandular Cells Not Otherwise SpecifiedAtypical Glandular Cells, Favor NeoplasticAdenocarcinoma in SituCervical AdenocarcinomaHuman Papillomavirus InfectionCervical Squamous Intraepithelial LesionCervical Squamous Cell Carcinoma
NCT05613283Peking University People's Hospital17,875
Unknown
不适用
Spectroscopy and Artificial Intelligence to Disrupt the Status Quo in Cervical Cancer ScreeningHPVCervical Cancer
NCT05236855IWK Health Centre200